معرفی
Sarah Kawasaki, MD, is an Associate Professor in both the Department of Psychiatry and Behavioral Health and the Department of Medicine's Division of General Internal Medicine at Penn State. She serves as Director of the Division of Addiction at the Pennsylvania Psychiatric Institute and is affiliated with the Penn State Neuroscience Institute. Her work focuses on opioid use disorder treatment, buprenorphine therapy, and methadone treatment protocols.
Her research contributes to UN Sustainable Development Goals related to health and well-being. Key research areas include substance abuse treatment optimization, clinical trial networks, and healthcare policy adaptations during public health crises like the opioid epidemic and pandemic.
Recent studies explore peer support systems in emergency departments, opioid screening tools, and pharmacotherapy strategies for pediatric cancer patients. Her work has been cited in over 50 news outlets and widely shared on academic platforms.
